THE USE OF KETOPROFEN NIOSOMES FOR FORMULATION OF SUSTAINED RELEASE TABLET DOSAGE FORM
Raslan, M. (2012). THE USE OF KETOPROFEN NIOSOMES FOR FORMULATION OF SUSTAINED RELEASE TABLET DOSAGE FORM. EKB Journal Management System, 46(2), 90-99. doi: 10.21608/ajps.2012.7119
Mohamed Raslan. "THE USE OF KETOPROFEN NIOSOMES FOR FORMULATION OF SUSTAINED RELEASE TABLET DOSAGE FORM". EKB Journal Management System, 46, 2, 2012, 90-99. doi: 10.21608/ajps.2012.7119
Raslan, M. (2012). 'THE USE OF KETOPROFEN NIOSOMES FOR FORMULATION OF SUSTAINED RELEASE TABLET DOSAGE FORM', EKB Journal Management System, 46(2), pp. 90-99. doi: 10.21608/ajps.2012.7119
Raslan, M. THE USE OF KETOPROFEN NIOSOMES FOR FORMULATION OF SUSTAINED RELEASE TABLET DOSAGE FORM. EKB Journal Management System, 2012; 46(2): 90-99. doi: 10.21608/ajps.2012.7119